G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

Biotechnology

G1 Therapeutics

Carol Candiano

Matt Vitug

Shannon Lusk

Shannon Lim

Whitney Page

Zaida Padron

Ryan Stewart

Jeremy Paul Ware

Raj Malik

Daniel Barnes

Darlene Burns

Daren Hill

Olu O. Oyeneye

Sandi James

Monica Thomas

Mike Townsend

Jonathan P. Lindberg

Oncology Sales and Marketing

Marketing and Communications

Leadership Team

Analytics and Development

Legal and Compliance

Clinical Operations Team

Teams at G1 Therapeutics